Search research articles
Contact Us
Filters
Showing results (11-20 of 64) with videos related to
Page
of 7
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 28, 2005
Determination of endogenous glycosaminoglycans derived disaccharides in human plasma by HPLC: validation and application in a clinical study
Vijay V Upreti, Manoj Khurana, Donna S Cox, et al.
Journal of Clinical Pharmacology
|
September 2, 2008
Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparin
Alan L Myers, Vijay V Upreti, Manoj Khurana, et al.
The Journal of the Association of Physicians of India
|
September 17, 2009
Osteogenesis imperfecta
S K Bhadada, R Santosh, A Bhansali, et al.
Medical Journal, Armed Forces India
|
October 1, 2016
Malaria - the Master Masquerader
V Upreti, V Gera, L C Chamania, et al.
Clinical Pharmacology : Advances and Applications
|
August 18, 2020
Dose Regimen Rationale for Panitumumab in Cancer Patients: To Be Based on Body Weight or Not
Michael Z Liao, Marloes Berkhout, Hans Prenen, et al.
Biomedical Chromatography : BMC
|
September 19, 2003
Quantitative determination of DRF-1042 in human plasma by HPLC: validation and application in clinical pharmacokinetics
Vijay V Upreti, Rao N V S Mamidi, Kasiram Katneni, et al.
Clinical Pharmacology and Therapeutics
|
September 25, 2023
A Mechanistic Physiologically-Based Pharmacokinetic Platform Model to Guide Adult and Pediatric Intravenous and Subcutaneous Dosing for Bispecific T Cell Engagers
Xinwen Zhang, Annie Lumen, Hansen Wong, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 24, 2022
Oncolytic viral kinetics mechanistic modeling of Talimogene Laherparepvec (T-VEC) a first-in-class oncolytic viral therapy in patients with advanced melanoma
Malidi Ahamadi, Johannes Kast, Po-Wei Chen, et al.
Journal of Clinical Pharmacology
|
September 5, 2025
Clinical Pharmacology Characterization of the First-In-Class Oncolytic Viral Therapy T-VEC in Adults and Pediatric Subjects
Xinwen Zhang, Bhavya Balu, Po-Wei Chen, et al.
Clinical Pharmacology : Advances and Applications
|
December 17, 2020
Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter]
Michael Z Liao, Johannes Kast, Marloes Berkhout, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 64) with videos related to
Sort By:
Page
of 7
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 28, 2005
Determination of endogenous glycosaminoglycans derived disaccharides in human plasma by HPLC: validation and application in a clinical study
Vijay V Upreti, Manoj Khurana, Donna S Cox, et al.
Journal of Clinical Pharmacology
|
September 2, 2008
Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparin
Alan L Myers, Vijay V Upreti, Manoj Khurana, et al.
The Journal of the Association of Physicians of India
|
September 17, 2009
Osteogenesis imperfecta
S K Bhadada, R Santosh, A Bhansali, et al.
Medical Journal, Armed Forces India
|
October 1, 2016
Malaria - the Master Masquerader
V Upreti, V Gera, L C Chamania, et al.
Clinical Pharmacology : Advances and Applications
|
August 18, 2020
Dose Regimen Rationale for Panitumumab in Cancer Patients: To Be Based on Body Weight or Not
Michael Z Liao, Marloes Berkhout, Hans Prenen, et al.
Biomedical Chromatography : BMC
|
September 19, 2003
Quantitative determination of DRF-1042 in human plasma by HPLC: validation and application in clinical pharmacokinetics
Vijay V Upreti, Rao N V S Mamidi, Kasiram Katneni, et al.
Clinical Pharmacology and Therapeutics
|
September 25, 2023
A Mechanistic Physiologically-Based Pharmacokinetic Platform Model to Guide Adult and Pediatric Intravenous and Subcutaneous Dosing for Bispecific T Cell Engagers
Xinwen Zhang, Annie Lumen, Hansen Wong, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 24, 2022
Oncolytic viral kinetics mechanistic modeling of Talimogene Laherparepvec (T-VEC) a first-in-class oncolytic viral therapy in patients with advanced melanoma
Malidi Ahamadi, Johannes Kast, Po-Wei Chen, et al.
Journal of Clinical Pharmacology
|
September 5, 2025
Clinical Pharmacology Characterization of the First-In-Class Oncolytic Viral Therapy T-VEC in Adults and Pediatric Subjects
Xinwen Zhang, Bhavya Balu, Po-Wei Chen, et al.
Clinical Pharmacology : Advances and Applications
|
December 17, 2020
Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter]
Michael Z Liao, Johannes Kast, Marloes Berkhout, et al.
Page
of 7